See what Saluda Medical, Axonics, and Medtronic were up to this time last year.

Katie Hobbins, Managing Editor

March 9, 2023

1 Min Read
Calendar pages
Archive Holdings Inc. / The Image Bank via Getty Images

A Wearable Vein Dilation Device Wins Breakthrough Designation

A vascular surgeon needed a better way to make patients’ veins bigger to prepare them for dialysis. So he invented one.

A New Challenger Has Entered the (U.S.) SCS Market

Saluda Medical has won FDA approval for its Evoke Spinal Cord Stimulation System.

Sherlock Raises $80M to Solve Diagnostic Barrier Dilemma

With this latest financing, the Boston, MA-based company has now raised a total of $111 million.

Axonics Closes a Portfolio Gap in Sacral Neuromodulation

FDA approval of a recharge-free system could drive additional market share gains for Medtronic's sole competitor in the sacral neuromodulation space.

Roche Launches Its Smallest Molecular System in UK

The new system has a smaller footprint, and is fully automated to improve testing volumes, and operational efficiency.

Medtronic Recalls TurboHawk Due to HawkOne Recall

After recalling the HawkOne Directional Atherectomy System earlier this year, Medtronic is also recalling (correcting) its TurboHawk Plus Directional Atherectomy System due to design similarities with the HawkOne.

Two-in-One Cancer Test Is the First of Its Kind

The blood-based test is the first ever to simultaneously identify if a patient has cancer and if it has spread.

Another Device SPAC Bites the Dust

Memic Innovative Surgery and Medtech Acquisitions have mutually terminated a planned merger.

A Leaner and More Focused Zimmer Biomet Dips Into AI

The Warsaw, IN-based company is launching an artificial intelligence model to predict post-operative recovery progress.

Most Innovative Medtech Companies in 2022

Is your company one of Fast Company's 10 most innovative medical device firms, now in their own category in the annual World’s Most Innovative Companies list?

About the Author(s)

Katie Hobbins

Managing Editor, MD+DI

Katie Hobbins is managing editor for MD+DI and joined the team in July 2022. She boasts multiple previous editorial roles in print and multimedia medical journalism, including dermatology, medical aesthetics, and pediatric medicine. She graduated from Cleveland State University in 2018 with a bachelor's degree in journalism and promotional communications. She enjoys yoga, hand embroidery, and anything DIY. You can reach her at [email protected].

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like